List of Excipients in API propoxyphene napsylate
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing propoxyphene napsylate
Detailed excipient profiles for propoxyphene napsylate
Excipient focus: ALUMINUM OXIDE
propoxyphene napsylate drug variants containing ALUMINUM OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0105 |
| >Company | >Ingredient | >NDC |
propoxyphene napsylate drug variants not containing ALUMINUM OXIDE
Excipient focus: CARNAUBA WAX
propoxyphene napsylate drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Altura Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 63874-201 |
| Keltman Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 68387-100 |
| >Company | >Ingredient | >NDC |
propoxyphene napsylate drug variants not containing CARNAUBA WAX
Excipient focus: CASTOR OIL
propoxyphene napsylate drug variants containing CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0378 |
| >Company | >Ingredient | >NDC |
propoxyphene napsylate drug variants not containing CASTOR OIL
Excipient focus: CELLULOSE, MICROCRYSTALLINE
propoxyphene napsylate drug variants containing CELLULOSE, MICROCRYSTALLINE
propoxyphene napsylate drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Altura Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 63874-201 |
| Keltman Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 68387-100 |
| >Company | >Ingredient | >NDC |
Excipient focus: COLLOIDAL SILICON DIOXIDE
propoxyphene napsylate drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Apotheca Inc | propoxyphene napsylate and acetaminophen | 12634-537 |
| Rebel Distributors Corp | propoxyphene napsylate and acetaminophen | 21695-280 |
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0378 |
| >Company | >Ingredient | >NDC |
propoxyphene napsylate drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CROSPOVIDONE
propoxyphene napsylate drug variants containing CROSPOVIDONE
propoxyphene napsylate drug variants not containing CROSPOVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Altura Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 63874-201 |
| Keltman Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 68387-100 |
| >Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 27
propoxyphene napsylate drug variants containing D&C RED NO. 27
| Company | Ingredient | NDC |
|---|---|---|
| Apotheca Inc | propoxyphene napsylate and acetaminophen | 12634-537 |
| Rebel Distributors Corp | propoxyphene napsylate and acetaminophen | 21695-280 |
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0105 |
| >Company | >Ingredient | >NDC |
propoxyphene napsylate drug variants not containing D&C RED NO. 27
Excipient focus: D&C YELLOW NO. 10
propoxyphene napsylate drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Apotheca Inc | propoxyphene napsylate and acetaminophen | 12634-537 |
| Rebel Distributors Corp | propoxyphene napsylate and acetaminophen | 21695-280 |
| >Company | >Ingredient | >NDC |
propoxyphene napsylate drug variants not containing D&C YELLOW NO. 10
Excipient focus: FD&C RED NO. 40
propoxyphene napsylate drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Altura Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 63874-201 |
| Keltman Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 68387-100 |
| >Company | >Ingredient | >NDC |
propoxyphene napsylate drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
propoxyphene napsylate drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0105 |
| >Company | >Ingredient | >NDC |
propoxyphene napsylate drug variants not containing FD&C YELLOW NO. 6
Excipient focus: HYDROXYPROPYL CELLULOSE
propoxyphene napsylate drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Apotheca Inc | propoxyphene napsylate and acetaminophen | 12634-537 |
| Rebel Distributors Corp | propoxyphene napsylate and acetaminophen | 21695-280 |
| >Company | >Ingredient | >NDC |
propoxyphene napsylate drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
propoxyphene napsylate drug variants containing HYPROMELLOSE
propoxyphene napsylate drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0104 |
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0105 |
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0378 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
propoxyphene napsylate drug variants containing HYPROMELLOSES
| Company | Ingredient | NDC |
|---|---|---|
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0104 |
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0105 |
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0378 |
| >Company | >Ingredient | >NDC |
propoxyphene napsylate drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE MONOHYDRATE
propoxyphene napsylate drug variants containing LACTOSE MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Altura Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 63874-201 |
| Keltman Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 68387-100 |
| >Company | >Ingredient | >NDC |
propoxyphene napsylate drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
propoxyphene napsylate drug variants containing MAGNESIUM STEARATE
propoxyphene napsylate drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
propoxyphene napsylate drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0104 |
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0105 |
| >Company | >Ingredient | >NDC |
propoxyphene napsylate drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
propoxyphene napsylate drug variants containing POLYETHYLENE GLYCOL
propoxyphene napsylate drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0104 |
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0105 |
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0378 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
propoxyphene napsylate drug variants containing POLYETHYLENE GLYCOLS
| Company | Ingredient | NDC |
|---|---|---|
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0104 |
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0105 |
| >Company | >Ingredient | >NDC |
propoxyphene napsylate drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
propoxyphene napsylate drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| Altura Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 63874-201 |
| Keltman Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 68387-100 |
| >Company | >Ingredient | >NDC |
propoxyphene napsylate drug variants not containing POLYSORBATE 80
Excipient focus: POVIDONE
propoxyphene napsylate drug variants containing POVIDONE
propoxyphene napsylate drug variants not containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Altura Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 63874-201 |
| Keltman Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 68387-100 |
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
propoxyphene napsylate drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0104 |
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0105 |
| >Company | >Ingredient | >NDC |
propoxyphene napsylate drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
propoxyphene napsylate drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Altura Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 63874-201 |
| Keltman Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 68387-100 |
| >Company | >Ingredient | >NDC |
propoxyphene napsylate drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: STARCH, CORN
propoxyphene napsylate drug variants containing STARCH, CORN
propoxyphene napsylate drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Altura Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 63874-201 |
| Keltman Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 68387-100 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
propoxyphene napsylate drug variants containing STEARIC ACID
propoxyphene napsylate drug variants not containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Altura Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 63874-201 |
| Keltman Pharmaceuticals Inc | propoxyphene napsylate and acetaminophen | 68387-100 |
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
propoxyphene napsylate drug variants containing TITANIUM DIOXIDE
propoxyphene napsylate drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0378 |
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
propoxyphene napsylate drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0104 |
| RedPharm Drug Inc | propoxyphene napsylate and acetaminophen | 67296-0105 |
| >Company | >Ingredient | >NDC |
propoxyphene napsylate drug variants not containing TRIACETIN
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
